2% (n = 229) taking clopidogrel alone, and 9 7% (n = 1017) taking

2% (n = 229) taking clopidogrel alone, and 9.7% (n = 1017) taking both ASA and clopidogrel. Clopidogrel alone or as dual antiplatelet

therapy was most frequently used prior to CEA and least frequently prior to oAAA group (CEA 16.1%, LEB 9.0%, EVAR 6.5%, oAAA 5%). Reoperation for bleeding was not significantly different among patients based on antiplatelet regimen (none 1.5%, ASA 1.3%, clopidogrel 0.9%, ASA/clopidogrel 1.5%, P = .74). When analyzed by operation type, no difference in reoperation for bleeding was seen across antiplatelet regimens. There was also no difference learn more in the incidence of transfusion among antiplatelet treatment groups (none 18%, ASA 17%, clopidogrel 0%, ASA/clopidogrel 24%, P = .1) and none when analyzed by individual operation type. Among patients who did require transfusion, there was no significant difference in the mean number of units of packed red blood cells required (none 0.7 units, ASA 0.5 units, clopidogrel 0 units, ASA/clopidogrel 0.6 units, P = .1) or when stratified by operation type.

Conclusions: Patients undergoing peripheral arterial surgery in whom clopidogrel was continued either alone or as part of dual antiplatelet click here therapy did not have significant bleeding complications compared with patients taking no antiplatelet therapy or ASA alone at the time of surgery. These data suggest that clopidogrel can safely be continued preoperatively

in patients with appropriate indications for its use, such as symptomatic carotid disease or recent drug-eluting coronary stents. (J Vase Surg 2011;54:779-84.)”
“BACKGROUND AND IMPORTANCE: Paragangliomas are rare tumors of neuroendocrine origin that arise from paraganglionic tissue of the extrachromaffin cell system. These lesions may be seen at various sites along the neuraxis. Primary thoracic paragangliomas have rarely been

reported in the literature, with secretory thoracic lesions being exceedingly rare as only 3 previous cases have been cited.

CLINICAL PRESENTATION: A 49-year-old woman presented with episodes of hypertension, palpitations, and diaphoresis. Workup revealed positive urine catecholamines and a thoracic spine mass extending into the thoracic apex. Preoperative alpha-blockade with phenoxybenzamine was used followed by posterior decompression and tumor resection. Arthrodesis Sulfite dehydrogenase from C5 to T4 was subsequently performed, and the patient received postoperative radiation.

CONCLUSION: Two years postoperatively, the patient has continued to have regression of her symptoms. We report a rare case of a catecholamine-secreting primary thoracic paraganglioma in a 49-year-old woman. These tumors should be treated carefully by the neurosurgeon with preoperative assistance from endocrinology for alpha-blockade, followed by gross total resection and postoperative radiation if residual tumor remains.”
“Polyploidization, a widespread phenomenon among plants, is considered a major speciation mechanism.

Comments are closed.